Please assess the completion status of the following clinical trial:

Trial Title: A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes~* Inadequate blood sugar control~* No current treatment with other medications to lower blood sugar~Exclusion Criteria:~* Major heart, liver or kidney problems~* Pregnant or breast feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 77 Years
- Healthy Volunteers: f

Study Arms:
- Saxagliptin and Metformin (A) (Type: EXPERIMENTAL): PLUS open-label pioglitazone (as needed as rescue medication)
- Saxagliptin and Metformin (B) (Type: EXPERIMENTAL): PLUS open-label pioglitazone (as needed as rescue medication)
- Saxagliptin and Placebo (C) (Type: EXPERIMENTAL): PLUS open-label pioglitazone (as needed as rescue medication)
- Metformin and Placebo (D) (Type: ACTIVE_COMPARATOR): PLUS open-label pioglitazone (as needed as rescue medication)

Based on this trial design, predict the completion outcome and termination type (if applicable).